NASDAQ •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 07/15/2026 16:00
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization506.89 mln
Float115 mln
Earnings Date08/04/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-3.79
Highly reliable
Relative Strength
24
/ 100
Significantly lagging
Debt / Equity
-1.28
Negative equity
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Aquestive Therapeutics is a US-based pharmaceutical company that develops and sells medicines in film-based formats, making treatments easier to take for patients with conditions such as epilepsy, opioid dependence, and ADHD. The company has several products already on the market, including treatments for seizures and allergic reactions, alongside a growing pipeline of new therapies currently in clinical trials. Founded in 2004 and based in Warren, New Jersey, Aquestive also licenses its proprietary film delivery technology to other drug makers targeting disorders of the central nervous system.
